Keiichi Ashikari

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiodiscoveryDisease surveillanceEpidemiological methodsOral medicine and pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2022
Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.

Takuma Higurashi, Keiichi Ashikari, Shigeki Tamura

|May 19, 2022
Endoscopic submucosal dissection without intubation for superficial pharyngeal cancer in a post-total laryngectomy patient.

Keiichi Ashikari, Hideyuki Chiba, Atsushi Nakajima

|Feb 06, 2021
Severe acute respiratory syndrome coronavirus 2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in coronavirus disease 2019 endemic areas: Prospective cross-sectional study in Japan.

Shigeta Miyake, Keiichi Ashikari, Shingo Kato

|Jan 28, 2021
Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection.

Keiichi Ashikari, Takashi Nonaka, Takuma Higurashi

|Jun 10, 2020
The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin.

Tsutomu Yoshihara, Yosuke Oikawa, Takayuki Kato

Pageof 1

Frequent Collaborators

2 joint publications

Tsutomu Yoshihara

2 joint publications

Atsushi Nakajima

2 joint publications

Takuma Higurashi

1 joint publications

Takayuki Kato